A rat model of distractibility: Effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission

被引:16
作者
Agmo, A [1 ]
Belzung, C [1 ]
Rodriguez, C [1 ]
机构
[1] UNIV TOURS,PSYCHOPHYSIOL LAB,TOURS,FRANCE
关键词
attention; amphetamine; amfonelic acid; dopamine; GABA agonists; schizophrenia;
D O I
10.1007/BF01271291
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A procedure for analyzing effects of drugs on distractibility is proposed. Rats are trained to traverse a straight runway with a sucrose solution as reinforcement. Once the response has been acquired, an additional runway ending in an empty box is connected. The time spent investigating this additional runway is the measure of distractibility. Amphetamine, 1 mg/kg i.p., increased distractibility. In rats that were never reinforced, amphetamine at a dose of 1 mg/kg reduced the time spent in the additional runway. This shows that the effects of amphetamine in the reinforced animals cannot be interpreted as enhanced exploration. Furthermore, the benzodiazepines diazepam (2 and 4 mg/kg, i.p.) and chlordiazepoxide (2.5, 5 and 10 mg/kg, i.p.), known to enhance exploration of novel environments, did not affect the time spent in the additional runway in sucrose-reinforced animals. It was concluded that the procedure indeed is a model of distractibility. The dopamine antagonist cis(Z)-flupenthixol, at a dose of 0.25 mg/kg, i.p.? blocked the effects of amphetamine, 1 mg/kg. Flupenthixol itself, in doses of 0.25 and 0.5 mg/kg, did not affect the time spent in the additional runway. This suggests that enhanced dopaminergic activity indeed is responsible for the effects. This proposal is further supported by experiments showing that the noradrenaline precursor dihydroxyphenylserine (10mg/kg + carbidopa, 50 mg/kg, both i.p.) and the noradrenergic neurotoxin DSP4 (50 mg/kg, i.p.) had no effect on distractibility. Moreover, amfonelic acid, a dopamine releaser with slight or no effect on noradrenergic neurotransmission, had effects very similar to those of amphetamine when given in doses of 0.25 and 0.5 mg/kg, i.p. A lower dose, 0.125 mg/kg, was ineffective. Taken together, these data suggest that enhanced dopaminergic neurotransmission increases distractibility in the rat. However, both amphetamine and amfonelic acid may stimulate serotonin release. Until serotonergic drugs have been tested, a contribution of this transmitter cannot be ruled out. The distraction procedure may constitute an animal model of some kinds of disordered information processing.
引用
收藏
页码:11 / 29
页数:19
相关论文
共 50 条
[1]   DOPAMINE AND SEXUAL-BEHAVIOR IN THE MALE-RAT - A REEVALUATION [J].
AGMO, A ;
FERNANDEZ, H .
JOURNAL OF NEURAL TRANSMISSION, 1989, 77 (01) :21-37
[2]  
AGMO A, 1991, N-S ARCH PHARMACOL, V344, P314
[3]   REWARD AND REINFORCEMENT PRODUCED BY DRINKING SUCROSE - 2 PROCESSES THAT MAY DEPEND ON DIFFERENT NEUROTRANSMITTERS [J].
AGMO, A ;
GALVAN, A ;
TALAMANTES, B .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 52 (02) :403-414
[4]   CATECHOLAMINES AND THE INITIATION OF SEXUAL-BEHAVIOR IN MALE-RATS WITHOUT SEXUAL EXPERIENCE [J].
AGMO, A ;
PICKER, Z .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (02) :327-334
[5]   BENZODIAZEPINE RECEPTOR LIGANDS AND SEXUAL-BEHAVIOR IN THE MALE-RAT - THE ROLE OF GABAERGIC MECHANISMS [J].
AGMO, A ;
FERNANDEZ, H .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 38 (04) :781-788
[6]   INFORMATION-PROCESSING AND ATTENTION DYSFUNCTIONS IN SCHIZOPHRENIA [J].
BRAFF, DL .
SCHIZOPHRENIA BULLETIN, 1993, 19 (02) :233-259
[7]   INVIVO POTENCIES OF ANTIPSYCHOTIC-DRUGS IN BLOCKING ALPHA-1 NORADRENERGIC AND DOPAMINE D2 RECEPTORS - IMPLICATIONS FOR DRUG MECHANISMS OF ACTION [J].
COHEN, BM ;
LIPINSKI, JF .
LIFE SCIENCES, 1986, 39 (26) :2571-2580
[8]  
CRIDER A, 1982, BIOL PSYCHIAT, V17, P351
[9]   A SELECTIVE ATTENTION-DEFICIT IN THE RAT FOLLOWING INDUCED DOPAMINE RECEPTOR SUPERSENSITIVITY [J].
CRIDER, A ;
BLOCKEL, L ;
SOLOMON, PR .
BEHAVIORAL NEUROSCIENCE, 1986, 100 (03) :315-319
[10]   EFFECTS OF ANTIPSYCHOTIC-DRUGS ON LATENT INHIBITION - SENSITIVITY AND SPECIFICITY OF AN ANIMAL BEHAVIORAL-MODEL OF CLINICAL DRUG-ACTION [J].
DUNN, LA ;
ATWATER, GE ;
KILTS, CD .
PSYCHOPHARMACOLOGY, 1993, 112 (2-3) :315-323